Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc., Lake Forest, IL.

FDA recall notice · announced April 16, 2014 · Hospira

Class III FDA/FSIS Class III: use is not likely to cause adverse health consequences.

The product

Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc., Lake Forest, IL.

Reason for recall

Labeling; Missing label; ampoules are missing the immediate container label

Notes

Distribution: Nationwide
Lot/code information: Lot: 221303A, 1OCT2014
Quantity: 237,850 ampoules
Status: Terminated
Products in this recall event:
- Demerol, meperidine HCL Inj. USP, 25 mg/0.5 mL (50 mg/mL), 0.5 mL ampoules, Rx only, NDC 0409-1203-01, Hospira, Inc., Lake Forest, IL. (D-1226-2014)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.